Time filter

Source Type

Patent
Sony Corporation and Japanese Foundation For Cancer Research | Date: 2015-11-04

An information processing unit includes: a diagnostic image input section that inputs the diagnostic image; an operation information obtaining section that obtains display operation history information representing an operation history of a user who controls displaying of the diagnostic image; a query image generation section that extracts a predetermined region of the input diagnostic image to generate a query image; a diagnosed image obtaining section that supplies the generated query image and the display operation history information to a diagnosed image search unit and obtains the diagnosed image obtained as a search result by the diagnosed image search unit; and a display control section that displays the diagnostic image and the obtained diagnosed image for comparison.


Patent
Sony Corporation and Japanese Foundation For Cancer Research | Date: 2016-04-27

[Object] To prevent an observer from feeling discomfort when an image is displayed by enlarging and scrolling. [Solving Means] A display control apparatus that is a first aspect of the present disclosure includes: an acquisition unit that obtains an input image; and a display control unit that displays the input image on a screen by scrolling the input image along a predetermined scroll line, the display control unit displaying the input image by scrolling the input image along the scroll line different according to a scroll speed that is a speed in the scrolling. The present disclosure can be applied to, for example, a case where a medical image is diagnosed.


Patent
Sony Corporation and Japanese Foundation For Cancer Research | Date: 2015-07-15

Provided is an information processing apparatus including an image supply unit that supplies a plurality of input images showing corresponding objects to an image processing unit and obtains a plurality of object images as an image processed result from the image processing unit, and a display control unit that synchronously displays the plurality of object images that have been obtained. The object images are regions including the corresponding objects extracted from the plurality of input images, and orientations, positions, and sizes of the corresponding objects of the plurality of object images are unified.


Patent
Japanese Foundation For Cancer Research and Jikei University School of Medicine | Date: 2014-06-30

A novel vaccine that can induce sufficiently high cell-mediated immunity is disclosed. The vaccine of the present invention contains, as an effective component, a polypeptide comprising a tandem repeat structure in which an MHC class I epitope region derived from an antigen protein and a spacer sequence are linked to each other alternately and repeatedly at least three times, or a recombinant vector which comprises a polynucleotide encoding said polypeptide and is capable of expressing said polypeptide in vivo. The spacer sequence is, for example, a sequence generated as an amino acid sequence inevitably encoded by a single base sequence which is designed such that the MHC class I epitope region derived from the antigen protein, an MHC class II epitope region derived from the antigen protein, and at least one higher-order-structure-stabilizing region are encoded by different reading frames in said single base sequence.


Patent
IMRA Inc and Japanese Foundation For Cancer Research | Date: 2016-08-24

Provide is a stable metallic nanostructure that causes no aggregation when surface-modified with biomolecule-reactive functional molecules. 30 to 90% of the surface of the metallic nanostructure is covered with at least one or more types of colloid-stabilizing functional molecules. Furthermore, the metallic nanostructure is covered with one or more types of biologically functional molecules.


Patent
Japanese Foundation For Cancer Research | Date: 2015-01-23

A polynucleotide, which is a novel causative gene for cancer, is elucidated, and, based on this finding, provided are a method for detecting the polynucleotide, or a polypeptide encoded by the polynucleotide; a kit and a primer set for the detection; a method for screening an inhibitor of the polypeptide; and a pharmaceutical composition for treating a cancer containing the inhibitor. In the detection method of the present invention, an FGFR3 fusion protein, or a fusion gene encoding the fusion protein, or a TACC3 fusion protein, or a fusion gene encoding the fusion protein, is detected in a sample derived from female genitalia obtained from a subject.


Patent
Japanese Foundation For Cancer Research | Date: 2015-04-08

The present invention provides a small compound targeting at TACC3. The present invention further provides a drug, particularly, an anticancer agent, comprising the small compound targeting at TACC3. A compound represented by the general formula (I) or a pharmaceutically acceptable salt, solvate, or ester derivative thereof binds to TACC3 and inhibits cell growth. Thus, these compounds can be used as drugs, particularly, anticancer agents.


Patent
Japanese Foundation For Cancer Research | Date: 2015-06-17

Probe sets which have been used in conventional FISH methods have a problem that the location of a labelled probe labelled with an orange fluorescent dye and the location of a labelled probe labelled with a green fluorescent dye is apart to some extent from each other and therefore both orange fluorescence and green fluorescence, rather than yellow fluorescence, are observed in some relative positions or angles between a fluorescence microscope and a target nucleic acid even when the target nucleic acid is not cleaved, which may lead to the false determination that the target nucleic acid is cleaved. [Solution] The following steps are involved: a step of bringing a hybridization solution into contact with a target nucleic acid (1), wherein the hybridization solution contains a probe set (5) that is composed of at least two labelled probes (5a, 5b) respectively labelled with different identifying factors and can hybridize with almost the full length of the sequence for the target nucleic acid (1); and a step of causing the identifying factors to develop the functions thereof to produce signals.


Patent
Japanese Foundation For Cancer Research | Date: 2015-09-25

The present invention provides a small compound targeting at TACC3. The present invention further provides a drug, particularly, an anticancer agent, comprising the small compound targeting at TACC3. A compound represented by the general formula (I) or a pharmaceutically acceptable salt, solvate, or ester derivative thereof binds to TACC3 and inhibits cell growth. Thus, these compounds can be used as drugs, particularly, anticancer agents.


Patent
Japanese Foundation For Cancer Research | Date: 2016-11-30

A polynucleotide, which is a novel causative gene for cancer, is elucidated, and, based on this finding, provided are a method for detecting the polynucleotide, or a polypeptide encoded by the polynucleotide; a kit and a primer set for the detection; a method for screening an inhibitor of the polypeptide; and a pharmaceutical composition for treating a cancer containing the inhibitor. In the detection method of the present invention, an FGFR3 fusion protein, or a fusion gene encoding the fusion protein, or a TACC3 fusion protein, or a fusion gene encoding the fusion protein, is detected in a sample derived from female genitalia obtained from a subject.

Loading Japanese Foundation for Cancer Research collaborators
Loading Japanese Foundation for Cancer Research collaborators